Gerard Stevens

Title: Gerard Stevens: Innovator in Blister Package Compliance

Introduction

Gerard Stevens is an inventive mind based in Australia, known for his contributions to the field of medication compliance through innovative blister packaging solutions. With a focus on improving patient adherence to drug regimens, Stevens has developed technologies that enhance the usability and reliability of blister packages.

Latest Patents

Stevens holds two notable patents that reflect his commitment to advancing medication compliance. The first patent, titled "Improvements Relating To Blister Package Compliance," describes a device designed to monitor patient compliance with a drug regimen. This device serves as a holder for storing a blister package and is equipped to sense whether a blister has not been opened. It generates a non-compliance signal when an unopened blister is detected and compares its position on the blister package to a prescribed medication plan.

The second patent, "Improvements Relating To A Blister Pack And Its Production," outlines a method for ensuring the correctness of a protected blister package assembled by a pharmacist. This invention involves checking the correlation of three binary codes on different components of the package to confirm correct assembly. The process includes printing two binary codes on the backing sheet and a third on a protective card, which is then scanned after assembly to verify the package's integrity.

Career Highlights

Gerard Stevens is currently associated with Manrex Pty. Ltd., where he continues to innovate in the field of blister packaging. His work focuses on enhancing the effectiveness of medication delivery systems, ensuring that patients adhere to their prescribed treatments.

Collaborations

Stevens collaborates with his coworkers Ian Stevens and Peter Stevens, contributing to a dynamic team that shares a common goal of improving patient compliance through innovative packaging solutions.

Conclusion

Gerard Stevens is a dedicated inventor whose work in blister package compliance has the potential to significantly impact patient adherence to medication regimens. His innovative patents and ongoing contributions to Manrex Pty. Ltd. highlight his commitment to enhancing healthcare through technology.